bivalirudin (Sandoz)
Welcome to the PulseAid listing for the bivalirudin drug offered from Sandoz. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz |
NON-PROPRIETARY NAME: | bivalirudin |
SUBSTANCE NAME: | BIVALIRUDIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-06-15 |
END MARKETING DATE: | 0000-00-00 |
bivalirudin HUMAN PRESCRIPTION DRUG Details:
Item Description | bivalirudin from Sandoz |
LABELER NAME: | Sandoz |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2015-06-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3158_1a07a375-7456-4e00-befe-07aaf2cdb4a3 |
PRODUCT NDC: | 0781-3158 |
APPLICATION NUMBER: | NDA020873 |
Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers: